SGRY: Surgery Partners Inc Price-to-Revenue Multiple

Brandmark of Surgery Partners Group (SGRY)

The reliability of Surgery Partners, Inc. (SGRY) is based on strong pricing power within the efficient surgical center segment. P/S fluctuations confirm this resilience, with the metric currently standing at 1.00. Stability is further bolstered by the business's complete isolation within the US, although global equipment supply chain disruptions could slow operational pace. This balance of factors renders the company a defensive asset.

SGRY surgerypartners.com Price-to-Revenue Ratio (07/04/2022 - 11/13/2026)

Surgery Partners Corp (SGRY) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart surgerypartners.com|SGRY - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Surgery Partners Corp|SGRY - Enterprise Value
- book capitalization data:
Net Asset Value per Share Surgery Partners|SGRY - Company Book Value|Market Value to Book Value surgerypartners.com|SGRY - Cumulative Company Assets
- debt obligations and liquidity statistics:
Debt to Capital Surgery Partners, Inc.|SGRY - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Surgery Partners Group|SGRY - Company Debts|Debts to Book Capitalization Ratio Surgery Partners Corp|SGRY - Company Long-Term Debts|Company Short-Term Debts Surgery Partners|Intermediate Coverage Ratio surgerypartners.com
- earnings and multiples data:
SGRY - Net Income|Future Net Profit Surgery Partners, Inc.|SGRY - Price to Earnings Ratio|Price to Future Earnings Ratio Surgery Partners Inc|SGRY - PEG Multiple|Company Value to EBITDA Surgery Partners Corp|SGRY - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Surgery Partners|SGRY - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months surgerypartners.com|SGRY - Net earnings per share growth this year|Expected earnings per share trend next year Surgery Partners, Inc.
- total revenue and sales volume data:
SGRY - Revenue and Sales Volume|Company Future Sales surgerypartners.com|SGRY - Price-to-Revenue Ratio|Market Cap to Projected Revenue Surgery Partners Corp
Fundamental company analysis:surgerypartners.com - SGRY
Mass-produced product of Surgery Partners Group

Surgery Partners, Inc. (SGRY) is enhancing margins by optimizing operating expenses through the outsourcing of service functions, which directly boosts the business's investment appeal. An analysis of the price-to-sales ratio allows for an assessment of market capitalization relative to gross revenue, helping investors determine the asset's degree of overvaluation and avoid the risk of deep drawdowns when purchasing the security at extreme values to ensure capital stability.

Competing companies

HCA (hcahealthcare.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple THC (Tenet Healthcare Corporation)|Price-to-Revenue Multiple Fresenius Medical Care AG|Solventum Inc. - P/S Multiple|Price to Sales Encompass|uhsinc.com (UHS) - Price-to-Revenue Ratio|davita.com - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue RDNT|Price to Sales Option Care OPCH|Market Cap to Revenue PINC (Premier Corp)|EYE (America's Best Contacts & Eyeglasses) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Progyny, Inc. PGNY|ARDT (ardenthealth.com) - Price-to-Sales Ratio|Select Medical Holdings - P/S Multiple|ASTH - P/S Multiple|Pediatrix Medical Group, Inc. (MD) - Price-to-Revenue Ratio|U.S. Physical Therapy, Inc. - Market Capitalization-to-Revenue Ratio|Market Cap to Revenue PNTG|ORGO (organogenesis.com) - Market Cap to Sales Volume|Price-to-Revenue Ratio Nutex Health (NUTX)|Auna S.A. - Market Cap to Revenue Ratio|P/S Multiple SBC (SBC Medical Group Holdings Inc.)|Evolus Corp (EOLS) - Price to Sales|CYH - Price-to-Revenue Ratio|Market Capitalization-to-Revenue Ratio SKIN (The Beauty Health)|mediwound.com (MDWD) - Price-to-Revenue Ratio|BTMD - Price-to-Revenue Coefficient|Market Cap to Revenue JYNT|DCGO: Market Capitalization-to-Revenue Ratio|P/S Multiple PIII|Price-to-Revenue Coefficient gaintherapeutics.com|Price-to-Revenue Ratio EUDA Health Holdings Limited EUDA|BMGL: Market Cap to Revenue Ratio|CollPlant Ltd - P/S Multiple|Cuprina Holdings Limited (CUPR) - Market Cap to Revenue|CCM (Concord Medical Services) - Market Cap to Revenue|AMS - Price-to-Revenue Coefficient|Price-to-Revenue Ratio MEDIROM Healthcare Group|Avalon GloboCare Corporation (ALBT) - Price-to-Revenue Coefficient|P/S Multiple DHAI|Carmell Corp (XAGE) - Price-to-Revenue Multiple|Price-to-Revenue Ratio NewGenIvf Group Limited NIVF|Market Capitalization-to-Revenue Ratio ATIP|CMAX: Market Cap to Revenue|Price to Sales Kindly MD Inc|MODV (LogistiCare) - Market Cap to Revenue|NVOS: Market Cap to Sales Volume|Price-to-Revenue Ratio SunLink Health Systems Inc.|BACK: Market Capitalization-to-Revenue Ratio